Tetanus

Cards (11)

  • Tetanus:
    • Caused by the tetanospasmin exotoxin released from Clostridium tetani
    • Tetanus spores are present in soil and may be introduced into the body from a wound
    • Tetanospasmin prevents the release of GABA
    • May be seen in IV drug users
  • Features:
    • prodrome fever, lethargy, headache
    • Trismus (lockjaw)
    • Risus sardonicus (facial spasms)
    • Opisthotonus - arched back, hyperextended neck
    • spasms
  • Management:
    • Supportive therapy including ventilatory support and muscle relaxants
    • IM human tetanus immunoglobulin for high-risk wounds
    • Antibiotics - metronidazole
  • Tetanus vaccine is currently given in the UK as part of the routine immunisation schedule:
    • 2 months (6-in-1)
    • 3 months (6-in-1)
    • 4 months (6-in-1)
    • 3-5 years (4-in-1 preschool booster)
    • 13-18 years (3-in-1 teenage booster)
  • Wound classified into:
    • Clean wound
    • Tetanus prone wound
    • High-risk tetanus prone wound
  • Clean wound:
    • Less than 6 hours old
    • Non-penetrating
    • Negligible tissue damage
  • Tetanus prone wound:
    • Puncture type injuries acquired in a contaminated environment e.g. gardening injuries
    • Wounds containing foreign bodies
    • Open fractures
    • Wounds or burns with systemic sepsis
    • Certain animal bites and scratches
  • High-risk tetanus prone wound:
    • Heavy contamination with material likely to contain tetanus spores e.g. soil, manure
    • Wounds or burns that show extensive devitalised tissue
    • Wounds or burns that require surgical intervention
  • Patient has had a full course of tetanus vaccines, with the last dose < 10 years ago:
    • no vaccine nor tetanus immunoglobulin is required, regardless of the wound severity
  • Patient has had a full course of tetanus vaccines, with the last dose > 10 years ago
    • Clean wound: no action required
    • if tetanus prone wound: reinforcing dose of vaccine
    • high-risk wounds (e.g. compound fractures, delayed surgical intervention, significant degree of devitalised tissue): reinforcing dose of vaccine + tetanus immunoglobulin
  • If vaccination history is incomplete or unknown
    • reinforcing dose of vaccine, regardless of the wound severity
    • for tetanus prone and high-risk wounds: reinforcing dose of vaccine + tetanus immunoglobulin